Abzena Introduces AbZelect™ Platforms to Enhance Cell Line Development Efficiency Toward IND Progress

AbZelect™ and AbZelectPRO™ platforms enable the rapid generation and selection of high-yielding mammalian CHO cell lines for therapeutic protei...

January 17, 2024 | Wednesday | News
WuXi Biologics Expanding Manufacturing Capacity in Massachusetts to Meet Growing Demand

he added capacity will further enhance WuXi Biologics’ commercial manufacturing capabilities in the U.S. The site is expected to employ 250 people...

January 08, 2024 | Monday | News
PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site

The new HPAPI GMP facility enables PharmaBlock to offer process R&D and kilo-scale production of HPAPIs and ADC toxins. It spans an area of 1000 m...

December 27, 2023 | Wednesday | News
Piramal Pharma Solutions Inaugurates ADC Manufacturing Expansion in Grangemouth, Scotland

Ribbon cutting and commissioning of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing facility that expands capacity by approxi...

December 19, 2023 | Tuesday | News
Charles River, Vertex Pharma Achieve Key Milestone in Cell Therapy Manufacturing Partnership

Charles River Laboratories International, Inc.  announced an important milestone in their strategic collaboration to manufacture CASGEVY™ (...

December 19, 2023 | Tuesday | News
Medivir Partners with Lonza for Fostrox GMP Manufacturing Campaign, Accelerating Approval Path for 2L HCC Testing and Commercialization

In addition, Lonza, Medivir's partner for process development and manufacture of drug substance, has developed a process suitable for commercial manufactur...

December 13, 2023 | Wednesday | News
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics

Abzena, the leading end-to-end bioconjugate and complex biologics CDMO has announced a partnership with ProteoNic Biosciences BV, to license their premium ...

December 07, 2023 | Thursday | News
Successful Development and Manufacturing of Complex Biologics with Integrated CMC Solutions

The complexity of new biologics means that these life-changing therapeutics require complicated development and manufacturing processes. Product-specific c...

December 07, 2023 | Thursday | Opinion
Global CDMO, Vetter, Advances Sustainability with Science Based Targets Initiative (SBTi) Membership.

As a result, Vetter has committed to the 1.5 degrees of global warming target. To this end, the CDMO has presented a sustainability strategy with concrete ...

December 06, 2023 | Wednesday | News
Samsung Biologics engages suppliers to advance global decarbonization targets

The company invited supplier companies and external ESG specialists to discuss ESG-related requirements and recommendations as well as share successful cas...

November 28, 2023 | Tuesday | News
Immutep Expands INSIGHT-003 Phase I Trial Site in Australia

This site expansion will support faster enrolment in this cost-efficient, investigator-initiated study evaluating eftilagimod alpha (efti) in combination w...

November 24, 2023 | Friday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...

November 17, 2023 | Friday | News
Evonik strengthens its portfolio of nanoparticle technologies and services for parenteral drug delivery

Three block copolymers added to RESOMER® portfolio of bioabsorbable polymers  New nanoparticle process technology increases options for n...

October 25, 2023 | Wednesday | News
LumaCyte Unveils Compact Radiance® Instrument for Biomanufacturing & QC in Advanced Therapy

LumaCyte, a leading innovator in advanced single cell analysis technology and instrumentation, is proud to announce the launch of their newly redesigned fl...

October 25, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close